Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis.

Monika KaushalAbdul RazackWaseemoddin PatelAbdul Kareem PullattayilAyush Kaushal

Published in: Journal of perinatology : official journal of the California Perinatal Association (2020)

Bevacizumab treatment for severe ROP is associated with increased risk of cognitive impairment and lower cognitive and language scores in preterm infants.

Keyphrases

preterm infants
cognitive impairment
autism spectrum disorder
early onset
low birth weight